Vertebrogenic Radiculopathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2017-05-09
Clinical Trial Update: Safety and Efficacy of Neuromultivit in Treatment of Vertebrogenic Radiculopathy [Phase 3]
A Phase 3 trial evaluating Neuromultivit for vertebrogenic radiculopathy has completed, reporting on its safety and efficacy.